Jiangsu Lanfeng Bio-chemical Stock Forum

Investors may be overlooking the company's poor growth rate, hoping for a business turnaround. However, continued negative growth rates could lead to a share price decline and a lower P/S ratio, risking shareholders' investments and potential investors paying an unnecessary premium.

Despite declining revenue, the company's P/S ratio surpasses its industry peers, suggesting less bearish investor sentiment. However, unless the recent medium-term revenue decline improves, shareholders may face a challenging period ahead.